|
US20020153508A1
(en)
|
2000-06-29 |
2002-10-24 |
Lynch Matthew Lawrence |
Cubic liquid crystalline compositions and methods for their preparation
|
|
BRPI0213425B8
(pt)
*
|
2001-10-19 |
2021-05-25 |
Idexx Lab Inc |
composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
|
|
US6946137B2
(en)
*
|
2001-10-19 |
2005-09-20 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
US7439268B2
(en)
*
|
2003-07-18 |
2008-10-21 |
Idexx Laboratories |
Compositions containing prodrugs of florfenicol and methods of use
|
|
US20050049210A1
(en)
*
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
EP1768650B1
(en)
*
|
2004-06-04 |
2008-07-16 |
Camurus Ab |
Liquid depot formulations
|
|
WO2007011385A2
(en)
|
2004-09-28 |
2007-01-25 |
Atrium Medical Corporation |
Heat cured gel and method of making
|
|
WO2006037049A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Application of a coating on a medical device
|
|
US9592324B2
(en)
|
2006-11-06 |
2017-03-14 |
Atrium Medical Corporation |
Tissue separating device with reinforced support for anchoring mechanisms
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US8124127B2
(en)
|
2005-10-15 |
2012-02-28 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US20060127437A1
(en)
*
|
2004-12-13 |
2006-06-15 |
Misty Anderson Kennedy |
Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
|
|
US20070059350A1
(en)
*
|
2004-12-13 |
2007-03-15 |
Kennedy John P |
Agents for controlling biological fluids and methods of use thereof
|
|
US8535709B2
(en)
*
|
2004-12-13 |
2013-09-17 |
Southeastern Medical Technologies, Llc |
Agents for controlling biological fluids and methods of use thereof
|
|
US8288348B2
(en)
*
|
2005-07-13 |
2012-10-16 |
Allergan, Inc. |
Cyclosporin compositions
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
US7550625B2
(en)
*
|
2007-10-19 |
2009-06-23 |
Idexx Laboratories |
Esters of florfenicol
|
|
WO2010063080A1
(en)
|
2008-12-05 |
2010-06-10 |
Commonwealth Scientific And Industrial Research Organisation |
Amphiphile prodrugs
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
WO2011050388A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Monash University |
Liquid crystal composition and method of use
|
|
WO2011145659A1
(ja)
*
|
2010-05-18 |
2011-11-24 |
富士フイルム株式会社 |
カロチノイド含有組成物及びその製造方法
|
|
EP2593141B1
(en)
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
AU2013294915C1
(en)
|
2012-07-26 |
2019-11-21 |
Camurus Ab |
Opioid formulations
|
|
PT2877155T
(pt)
|
2012-07-26 |
2020-12-18 |
Camurus Ab |
Formulações de opioides
|
|
CN111432805B
(zh)
|
2017-11-27 |
2023-02-17 |
梅克里内科尼蒂翁公司 |
3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂
|
|
AU2019258590B2
(en)
|
2018-04-26 |
2022-09-08 |
NanoMed Holdings Pty Ltd |
Gemcitabine amphiphile prodrugs
|
|
US12194014B2
(en)
|
2018-06-21 |
2025-01-14 |
NanoMed Holdings Pty Ltd |
Platinum-based amphiphile prodrugs
|
|
EP4284182A1
(de)
*
|
2021-01-29 |
2023-12-06 |
IOI Oleo GmbH |
Polyglycerolfettsäureesterhaltige zusammensetzung
|